JDVFX | VIVIX | JDVFX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 4.139 | 4.165 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16B | 193B | 8% |
Annual Yield % from dividends | 0.82 | 2.37 | 35% |
Returns for 1 year | 1.48 | 13.44 | 11% |
Returns for 3 years | 3.30 | 23.92 | 14% |
Returns for 5 years | 16.82 | 47.20 | 36% |
Returns for 10 years | 27.94 | 105.52 | 26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VIXM | 15.09 | 0.40 | +2.72% |
ProShares VIX Mid-Term Futures | |||
BSJQ | 23.48 | -0.02 | -0.09% |
Invesco BulletShares 2026 HY Corp Bd ETF | |||
MOAT | 92.11 | -0.68 | -0.73% |
VanEck Morningstar Wide Moat ETF | |||
BBP | 63.29 | -0.54 | -0.85% |
Virtus LifeSci Biotech Products ETF | |||
JSML | 64.95 | -1.93 | -2.89% |
Janus Henderson Small Cap Gr Alpha ETF |